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Background:  Innate immune cell oxidative 
burst is needed to combat pathogens. 
Results: Loss of Shp2 phosphatase reduces, 
while increased Shp2 phosphatase function 
enhances ROS production.  
Conclusion:  The Shp2 phosphatase domain 
is specifically required for optimal oxidative 
burst in macrophages. 
Significance:  Humans bearing aberrancies of 
Shp2 phosphatase or of Shp2-containing 
signaling pathways may be prone to impaired 
or excessive ROS production. 
 
ABSTRACT 
Macrophages are vital to innate immunity, and 
express pattern recognition receptors and 
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integrins for the rapid detection of invading 
pathogens.  Stimulation of Dectin-1 and 
complement receptor 3 (CR3) activates Erk- and 
Akt-dependent production of reactive oxygen 
species (ROS).  Shp2, a protein tyrosine 
phosphatase encoded by Ptpn11, promotes 
activation of Ras-Erk and PI3K-Akt and is 
crucial for hematopoietic cell function; however, 
no studies have examined Shp2 function in 
particulate-stimulated ROS production.  
Maximal Dectin-1-stimulated ROS production 
corresponded kinetically to maximal Shp2 and 
Erk phosphorylation.  Bone marrow derived 
macrophages (BMMs) from mice with a 
conditionally deleted allele of Ptpn11 
(Shp2flox/flox;Mx1Cre+) produced significantly 
lower ROS levels compared to control BMMs.  
Although yellow fluorescent protein (YFP)-
tagged phosphatase dead Shp2-C463A was 
strongly recruited to the early phagosome, its 
expression inhibited Dectin-1- and CR3-
stimulated phospho-Erk and ROS levels, placing  
Shp2 phosphatase function and Erk activation 
upstream of ROS production.  Further, BMMs 
expressing gain-of-function (GOF) Shp2-D61Y 
or Shp2-E76K and peritoneal exudate 
macrophages (PEMs) from 
Shp2D61Y/+;Mx1Cre+ mice produced 
significantly elevated levels of Dectin-1- and 
CR3-stimulated ROS which was reduced by 
pharmacologic inhibition of Erk.  Signal 
regulatory protein  (SIRP) is a myeloid 
inhibitory immunoreceptor that requires 
tyrosine phosphorylation to exert its inhibitory 
effect.  YFP-Shp2C463A-expressing cells have 
elevated phospho-SIRP levels and an increased 
Shp2- SIRP interaction compared to YFP-WT 
Shp2-expressing cells.  Collectively, these 
findings indicate that Shp2 phosphatase 
function positively regulates Dectin-1- and CR3-
stimulated ROS production in macrophages by 
de-phosphorylating and thus mitigating the 
inhibitory function of SIRPand by promoting 
Erk activation. 
 
INRODUCTION 
Macrophages are phagocytic cells that function as 
the body’s global first-line defense against invading 
pathogens.  Upon interaction with pathogen-
producing stimuli, macrophages internalize large 
particulate microorganisms and generate 
microbicidal reactive oxygen species (ROS) 
produced by activated nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase (1).  
NADPH oxidase is composed of membrane-
integrated gp91phox and p22phox as well as the four 
cytosolic components p47phox, p67phox, p40phox, and 
Rac2 (2,3).  Individuals with chronic 
granulomatous disease (CGD) have inherited 
germline mutations within variable components of 
the NADPH oxidase complex, and suffer from 
recurrent, life-threatening bacterial and fungal 
infections, highlighting the imperative nature of 
competent ROS production by the innate immunity 
(4,5). 
 
Shp2, a protein tyrosine phosphatase encoded by 
the PTPN11 gene, promotes activation of Ras-Erk 
signaling and plays an essential role in 
hematopoietic cell development (6,7).  Genetic 
disruption of murine Ptpn11 within hematopoietic 
lineages leads to rapid loss of blood cell production 
of all lineages (8,9).  In humans, gain-of-function 
PTPN11 mutations are commonly found in children 
with Noonan syndrome and juvenile 
myelomonocytic leukemia (JMML) (10,11).  
Although no PTPN11 mutations have been found to 
be associated with clinical immune deficiency, 
Shp2 is a critical signaling component of Leptin 
Receptor-dependent protection against the parasitic 
pathogen, Entamoeba histolytica (12), and children 
bearing germline loss-of-function LEPR mutations 
are susceptible to respiratory infections (13).  
Further, previous studies found that Shp2 regulates 
the phosphorylation of transcription factors 
HoxA10 and ICSBP, leading to transcriptional 
repression of the NADPH oxidase components 
gp91phox and p67phox and preventing myeloid 
terminal differentiation (14,15); however, no 
studies have examined the function of Shp2 
phosphatase in ROS production in terminally 
differentiated macrophages or neutrophils, which 
may reveal a novel role for Shp2 in innate immunity 
and ROS production.  
 
Macrophages are capable of detecting and 
responding to pathogen-derived molecules such as 
fungal glucans and lipopolysaccharides, as they 
express cell surface pattern recognition receptors 
(PRRs) such as C-type lectins.  Dectin-1 is a C-type 
lectin expressed on macrophages that responds to 
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-glucan-containing particles derived from fungal 
cell walls and stimulates Src- and Syk-dependent 
signaling (16).  Dectin-1 stimulation results in 
activation of the Ras-Erk pathway, production of 
microbicidal ROS, and induction of expression of 
the inflammatory cytokines, TNF and IL6.  In 
humans, loss-of-function mutations in DECTIN-1 
confer a state of increased susceptibility to 
mucocutaneous C. albicans and invasive 
aspergillosis (17,18).   
 
Based on the known high expression of Shp2 in 
macrophages and its well-defined role as a positive 
regulator of the Ras-Erk pathway, we hypothesized 
that Shp2 promotes normal innate immunity by 
positively upregulating particulate-stimulated 
NADPH oxidase activation and abrupt production 
of ROS, known as oxidative burst.  To address this 
hypothesis, we examined the correlation of Shp2 
activation to peak ROS production in zymosan-
stimulated peritoneal exudate macrophages (PEMs) 
and examined the putative placement of Shp2 in the 
Dectin-1-stimulated pathway employing genetic 
studies and pharmacologic studies using the Syk 
inhibitor, R406, and the Erk inhibitor, SCH772984.  
Genetic disruption of Ptpn11 resulted in reduced 
macrophage ROS production in response to both 
zymosan (Dectin-1 stimulation) and serum 
opsonized zymosan (SOZ, complement receptor 3 
stimulation), indicating a positive function of Shp2 
in oxidative burst.  Structure-function studies using 
various Shp2 loss-of-function and gain-of-function 
constructs indicated that the phosphatase function 
of Shp2 is specifically required for positive 
regulation of particulate-stimulated oxidative burst.  
Mechanistic studies demonstrated that Shp2 exerts 
its positive effect on ROS generation by de-
phosphorylating the myeloid inhibitory 
immunoreceptor, SIRP (signal regulatory protein 
), and by promoting Erk activation. 
 
EXPERIMENTAL PROCEDURES 
Reagents.  Chemicals were purchased from Sigma-
Aldrich (St. Louis, MO) unless otherwise stated.  
Phosphate-buffered saline (PBS) pH 7.2, 
penicillin/streptomycin, neomycin, IMDM and 
DMEM were from Invitrogen Life Technologies 
(Carlsbad, CA); fetal calf serum (FCS) was from 
HyClone Laboratory (Logan, UT). The ECL 
detection kit came from Pierce (Rockford, IL). 
Rabbit polyclonal antibody against p40phox and 
mouse monoclonal antibody T-Syk were from 
Upstate Biotechnology (Lake Placid, NY), rabbit 
polyclonal antibody against p47phox was from Santa 
Cruz Biotechnology (Santa Cruz, CA), and 
monoclonal antibody against p67phox was from 
BD Biosciences (Franklin Lakes, NJ).  Rabbit 
polyclonal and mouse monoclonal antibodies 
against Shp2 was from Santa Cruz Biotechnology 
(SC-280) and BD Bioscience (#610621), 
respectively. Anti-SIRP polyclonal antibody was 
from Abcam (#53721) and mouse dectin-
1/CLEC7A antibody (Clone 218838) was from 
R&D Systems, Inc. (Minneapolis, MN).  Anti-
phospho-SIRP was generated as previously 
described (19).  Anti-gp91phox mAb 54.1 and anti-
p22phox mAb NS2 were kindly provided by A. J. 
Jesaitis (Montana State University) (20).  All the 
other antibodies, including anti-phospho-
antibodies, were obtained from Cell Signaling 
Technology (Beverly, MA) unless otherwise stated.  
Zymosan A from Saccharomyces cerevisiae was 
from Sigma (Z-4250).  The fluorescein 
isothiocyanate (FITC)–labeled zymosan particles 
were from Life Technologies.  Phycoerythrin (PE)-
Mac-1 and allophycocyanin (APC)-F4/80 were 
from BD Pharmingen. 
 
Animal Husbandry.  Mice bearing a conditional 
gain-of-function (GOF) Ptpn11 allele (LSL-
Shp2D61Y/+) or a conditional floxed Ptpn11 allele 
(Shp2flox/flox) have been described (9,21,22) and 
were crossed with mice bearing the Mx1Cre 
transgene to generate experimental 
(Shp2D61Y;Mx1Cre+ or Shp2f/f;MxCre+) and 
negative control (Shp2D61Y;Mx1Cre- or 
Shp2f/f;MxCre-) animals.  All animals received 
three intraperitoneal injections with 300 µg 
polyI:polyC (GE Healthcare) to induce Ptpn11 
recombination.  All mice were maintained under 
specific pathogen-free conditions at the Indiana 
University Laboratory Animal Research Center 
(Indianapolis, IN) and this study was approved by 
the Institutional Animal Care and Use Committee 
of the Indiana University School of Medicine. 
 
Plasmid construction.  The cDNAs encoding 
wildtype (WT) Shp2 or Shp2-R32K and Shp2-
C463A mutants were cloned into EcoRI and KpnI 
sites of pEYFP-N1 (Clontech; San Diego, CA) to 
generate yellow fluorescent protein (YFP)-tagged 
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Shp2 constructs, and the constructs were confirmed 
by sequencing.   The YFP-tagged Shp2 cDNAs 
were then ligated into pMSCV (Clontech) for use 
in generation of retroviral supernatants.  
Preparation and characterization of the pMIEG3-
WT Shp2, Shp2-D61Y, and Shp2-E76K was 
described previously (23).  
 
Retroviral transduction of bone marrow (BM) 
and macrophage differentiation.  Retroviral 
transduction of murine bone marrow low density 
mononuclear cells (LDMNCs, C57Bl/6 
background) with MSCV-WT Shp2-YFP, Shp2-
R32K-YFP, or Shp2-C463A-YFP  or with MIEG3-
WT Shp2, Shp2-D61Y, or Shp2-E76K was 
performed as described (23,24).  Transduced cells 
were sorted by fluorescence activated cell sorting 
(FACSCalibur, BD; Franklin Lakes, NJ) prior to 
macrophage differentiation, as described (23).  
Activity, immunostaining, and live images were 
analyzed 6-7 days after macrophage differentiation. 
 
Peritoneal exudate macrophage (PEM) 
preparation.  Eight weeks after polyI:polyC 
treatment, Shp2D61Y;Mx1Cre+ and negative 
control Shp2D61Y;Mx1Cre- animals were injected 
with 1 mL of 3% thioglycollate to induce peritoneal 
inflammation.  72 hours later, peritoneal cells were 
harvested by lavage with PBS, and macrophages 
were isolated by culturing cells at 1×106 cells/mL in 
IMDM with 20% heat-inactivated (HIA)-serum and 
2% Penicillin-Streptomycin (P/S) in a tissue culture 
dish for 2 hours, and then removing non-adherent 
cells (25).  After overnight incubation in IMDM 
with 20% HIA-serum and 2% P/S, PEMs were used 
to perform functional and biochemical analyses. 
 
Preparation of particulate stimuli.  Zymosan and 
serum opsonized-zymosan A particles (SOZ, 
Sigma Z-4250) were prepared as previously 
described (26-28).  A synchronized phagocytosis 
assay was used for zymosan- or SOZ-induced 
NADPH oxidase activity assays (29,30).  Briefly, 
macrophages in 200 μL PBSG were incubated on 
ice for 5 minutes in 50 μM luminol and 20 U/mL 
HRP, then 25 μL cold zymosan or SOZ (final 
concentration: 400 μg/mL) were added. Cells and 
particles were spun at 1200rpm for 5 minutes at 
4°C, then immediately placed at 37°C in the 
luminometer.  
Reactive oxygen species (ROS) detected by 
chemiluminescence in intact cells.  ROS 
production during synchronized phagocytosis of 
SOZ or zymosan stimulation was measured in the 
presence of 20 µM luminol with 20 U/mL 
horseradish peroxidase (HRP) (24,30,31).  An 
Lmax microplate luminometer (Molecular Devices, 
Sunnyvale, CA) was used to record luminescence 
as previously described (24,26).  For some 
experiments, macrophages were pre-incubated at 
37º C with Syk inhibitor, R406, NADPH oxidase 
inhibitor, diphenyleneiodonium chloride (DPI), or 
Erk inhibitor for 30 minutes. 
 
Phagocytosis assays.  Synchronized phagocytosis 
was performed as previously described (24).  
Briefly, 2×106 macrophages were washed with PBS 
and resuspended in 3 mL PBSG, added to 6-well 
plate, and kept on ice for 5minutes, followed by 
adding 300 L cold SOZ or zymosan  (4.4 g/L in 
PBSG) for a final concentration of 400 g/mL.  
Plates were immediately centrifuged at 1200 rpm 
for 5 min at 4°C, and then transferred to 37°C for 
indicated time.  For biochemical studies, cells were 
washed in PBS X 3, and 60 L lysis buffer was 
added to each well.  For the phagocytic assays, the 
macrophages were plated at 0.5×106 cells/well in 
12-well plates in macrophage differentiation 
medium incubated at 37°C for 24 hours.  After 
washing, fluorescein isothiocyanate (FITC)–
labeled zymosan particles (100 g/mL) (Molecular 
Probes, Life Technologies) were added to the cells, 
and cells were incubated at 37°C for indicated time.  
The cells were then put on ice and washed 
thoroughly to remove unbound particles with PBS.  
The macrophages were detached and analyzed by 
flow cytometry immediately. 
 
Western blots.  Macrophages were lysed in lysis 
buffer containing 50 mM Hepes (pH 7.4), 150 mM 
NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM 
MgCl2, 1 mM  EGTA,100 mM NaF, 10 mM sodium 
pryophosphate, 1 mM phenylmethylsulfonyl 
fluoride (PMSF), 1X protease inhibitor cocktail set 
I (Calbiochem),  1 mM Na3VO4, and 0.1 mM ZnCl2 
(32,33).  10 µg protein lysate was subjected to SDS-
PAGE and immunoblotting using ECL detection 
(24,26). YFP expression was also analyzed by flow 
cytometry (FACSCalibur, BD) (24,26). 
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Immunoprecipitation (IP).  100 g cell lysates 
were adjusted to a total volume of  1 mL in IP 
incubation buffer (50 mM Hepes, pH 7.4, 1% 
Triton X-100, 150 mM NaCl, 5 mM  EDTA, 0.1% 
bovine serum albumin (BSA),  50 mM NaF, 1mM 
PMSF, 1X protease inhibitor cocktail set I 
(Calbiochem),  1 mM Na3VO4, and 0.1 mM ZnCl2).  
2 g anti-Shp2 polyclonal antibody (SC-280, Santa 
Cruz Biotechnology) was added to the cell lysates 
and incubated at 4oC for 1 hour, followed by 
addition of 25 L Protein A/G PLUS-Agarose 
(Santa Cruz Biotechnology) and incubated for 2 – 3 
h at 4oC. The beads was washed three times in 
buffer (50 mM Hepes, pH 7.4, 1% Triton X-100, 
120 mM NaCl, 5 mM  EDTA, 50 mM NaF, 1 mM 
PMSF, 1X protease inhibitor cocktail set I 
(Calbiochem),  1 mM Na3VO4, and 0.1 mM ZnCl2), 
resuspended in 25L 2X SDS-PAGE loading 
buffer, boiled for 5 min, and supernatant was 
subjected to SDS-PAGE and immunoblotting with 
anti-phospho-SIRP or anti-Shp2. 
 
Immunofluorescence microscopy.  
Immunostaining for Shp2 was performed after 
synchronized phagocytosis.  Briefly, 1×106 PEMs 
or BMMs in 2 mL PBSG were added to coverslip-
bottomed dishes (MatTek Cultureware, Ashland, 
MA), and incubated for 5 min on ice prior to adding 
300 L zymosan or SOZ (final concentration 400 
g/mL).  The cells and particles were spun down at 
1200 rpm for 5 min at 4°C, then incubated at 37C 
for 10 min for PEMs or 30min for BMMs.  
Phagocytosis was terminated by placing the cells on 
ice, which were then washed with cold PBS, fixed 
with 4% paraformaldehyde for 10 min at room 
temperature, permeabilized with 0.1% TritonX-100 
in PBS, blocked with 10% goat serum plus 2% BSA 
in PBS, and immunostained with anti-Shp2 
followed by Alexa-568 goat anti-rabbit IgG.  For 
co-staining, cells were immunostained with anti- 
SIRP polyclonal Ab (#53721, Abcam) and anti-
Shp2 mAb (#610621, BD Bioscience) followed by 
Alexa-568 goat anti-rabbit IgG and Alexa-488 goat 
anti-mouse IgG1.  Cells were imaged on a spinning-
disk (CSU10) confocal system mounted on a Nikon 
TE-2000U inverted microscope with an Ixon air-
cooled EMCCD camera (Andor Technology, South 
Windsor, CT) and a Nikon Plan Apo 100X 1.4 N.A. 
objective.  Images shown are representative of at 
least 3 independent experiments. 
 
Live cell imaging by confocal videomicroscopy.  
SOZ-induced phagocytosis in WT mouse BMMs 
expressing YFP-tagged WT Shp2, Shp2-C463A, or 
Shp2-R32K was filmed using a spinning-disk 
(CSU10) confocal system mounted on a Nikon TE-
2000U inverted microscope with an Ixon air-cooled 
EMCCD camera (Andor Technology, South 
Windsor, CT) and a Nikon Plan Apo 100X 1.4 N.A. 
objective as described previously. All images were 
analyzed with Metamorph software (Universal 
Imaging; Downington, PA). Each type of 
experiment was performed on at least 3 
independent occasions.  Live images were collected 
in a single confocal plane (1 M) with 514 nm 
excitation and 0.3 sec exposure with a time lapse of 
10 sec. 
 
Statistical Analysis.  Groups were compared using 
unpaired, two-tailed, Student’s t test. 
 
RESULTS 
Shp2 functions downstream of Syk in Dectin-1 
signaling.  Previous work has demonstrated that 
Dectin-1 stimulation with -glucan-containing 
particles leads to Ras-Erk pathway activation and 
ROS production in a Syk-dependent manner (16).  
Given that the protein tyrosine phosphatase, Shp2, 
positively regulates Ras-Erk pathway signaling and 
is known to be crucial for normal hematopoietic cell 
development and function (6,7), we hypothesized 
that Shp2 functions in the Dectin-1 signaling 
pathway to promote particulate-stimulated ROS 
production in macrophages.  To address this 
hypothesis, we used peritoneal exudate 
macrophages (PEMs) to examine the kinetics of 
Shp2 phosphorylation at tyrosine 580 (Y580, 
indicating that Shp2 is in its open, active 
conformation) (34) in response to zymosan, and 
correlated Shp2 phosphorylation with peak ROS 
production and activation of the known Dectin-1-
responsive signaling molecules, Syk, Erk, and Akt.  
Zymosan exposure induced maximal ROS 
production at 10 minutes post-stimulation, and this 
time point corresponded to maximal activation of 
Syk, Shp2, and Erk (Figs. 1A and 1B).  As 
expected, Akt was also activated by zymosan 
stimulation; however, peak Akt activation was at 
one hour post-stimulation, and after the peak ROS 
production, suggesting that Akt serves to support 
sustained ROS production rather than promoting 
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immediate and maximal ROS production. Upon 
treatment with the Syk inhibitor, R406, ROS 
production was strongly suppressed, which 
correlated kinetically with reduced Syk, Shp2, Erk, 
and Akt activation (Figs. 1C and 1D).  Importantly, 
R406 treatment did not suppress expression of 
p22phox and gp91phox, (Figs. 1D), suggesting that 
reduced ROS is not due to altered expression of 
NADPH oxidase components, but is instead due to 
reduced NADPH oxidase function. 
 
Genetic disruption of Shp2 results in reduced 
zymosan- and serum opsonized zymosan (SOZ)-
stimulated ROS production.  We next used a 
mouse model bearing a conditionally floxed allele 
of Ptpn11 (Shp2f/f;Mx1Cre+) (9).  Shp2f/f;Mx1Cre+ 
and negative control Shp2f/f;Mx1Cre- mice were 
treated with 300 g polyI:polyC every other day for 
3 doses.  Four – six weeks following polyI:polyC 
treatment, animals were euthanized followed by 
isolation of bone marrow low density mononuclear 
cells (LDMNCs) which were cultured in M-CSF to 
generate bone marrow-derived macrophages 
(BMMs).  Based on Mac1 and F4/80 staining, 
cultured BMMs from the Shp2f/f;Mx1Cre+ and 
Shp2f/f;Mx1Cre- mice demonstrated a similar level 
of terminal differentiation (Fig. 2A).  However, 
following stimulation with zymosan (Dectin-1 
stimulation) or with SOZ (CR3 stimulation), the 
Shp2f/f;Mx1Cre+ BMMs demonstrated a reduced 
oxidative burst compared to the Shp2f/f;Mx1Cre- 
BMMs (Figs. 2B, 2C, and 2D).  As Shp2 had 
previously been found to regulate FcR-induced 
phagocytosis in macrophages (35), we next 
examined if the reduced ROS production was due 
to a global reduction in phagocytosis; however, the 
phagocytic index was similar for the 
Shp2flox/flox;Mx1Cre+ and Shp2flox/flox;Mx1Cre- 
BMMs (Fig. 2E).  Moreover, we found that 
expression of various components of the NADPH 
oxidase complex (p22phox, gp91phox, p40phox, p47phox, 
p67phox) were expressed at similar levels in the 
Shp2f/f;Mx1Cre+ and Shp2f/f;Mx1Cre- BMMs (Fig. 
2F), indicating that the reduced ROS seen in the 
Shp2flox/flox;Mx1Cre+ BMMs is  not due to reduced 
expression of phox proteins. 
 
When examining Dectin-1 signaling, both total 
Shp2 and phospho-Shp2 levels were reduced in the 
Shp2f/f;Mx1Cre+ BMMs, and as anticipated Erk 
activation was reduced in a correlative fashion (Fig. 
2G).  Reduced Shp2 expression did not have an 
effect on overall phospho-Akt levels, suggesting 
that the Shp2-regulated Erk activation is more 
relevant to abrupt and maximal ROS production.  
Consistent with the pharmacologic data using 
R406, reduced Shp2 expression and activation did 
not cause reduced activation of Syk.  Collectively, 
these functional and biochemical studies suggest 
that Shp2 functions downstream of Syk in the 
Dectin-1-stimulated signaling pathway, and 
positively upregulates Dectin-1-stimulated ROS 
levels. 
 
Shp2 is recruited to the phagosome and requires 
tyrosine phosphatase function to promote ROS 
production.  Given the positive role of Shp2 on 
zymosan- and SOZ-stimulated ROS production, we 
next imaged SOZ-stimulated BMMs to determine if 
Shp2 is recruited to the phagosome membrane, the 
location of the NADPH oxidase complex.  
Consistent with the positive functional findings, we 
found that Shp2 strongly co-localizes with F-actin 
on the phagosomal cup and early phagosomes (Fig. 
3A). 
 
To define the biochemical role of Shp2 in ROS 
production, we generated yellow fluorescent 
protein (YFP)-tagged Shp2 constructs bearing 
mutation of the N-SH2 (R32K) or phosphatase 
(C463A) domains (Fig. 3B).  These constructs were 
retrovirally introduced into murine bone marrow 
LDMNCs followed by sorting to enrich for YFP+ 
cells and generation of bone marrow-derived 
macrophages (BMMs).  Sorted, differentiated 
macrophages expressed similar levels of each of the 
Shp2 constructs based on YFP expression (Fig. 3C) 
and immunoblot analysis (Fig. 3D), expressed 
similar levels of the NADPH oxidase components, 
p67phox, p22phox, and gp91phox (Fig. 3D), and 
differentiated similarly based on Mac1 and F4/80 
expression (Fig. 3E).  When subjected to zymosan 
or SOZ stimulation, mutation of either the N-SH2 
domain or the phosphatase domain resulted in 
reduced ROS production (Fig. 3F).  Given the 
functional effect of the N-SH2 domain and 
phosphatase dead mutants, we next compared the 
subcellular phagosomal membrane localization of 
WT Shp2 to the point mutants using time-lapse 
confocal videomicroscopy.  The N-SH2 domain 
mutant was not recruited to the phagosome; 
however, the phosphatase dead mutant was strongly 
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recruited to the phagosome, even more intensely 
than WT Shp2 (Fig. 3G).  These findings suggest 
that the phosphatase function of Shp2 specifically 
is needed for the positive regulation of NADPH 
oxidase. 
 
Gain-of-function (GOF) Shp2 mutants enhance 
zymosan- and SOZ-stimulated ROS production.  
Based on the finding that expression of phosphatase 
dead Shp2-C463A resulted in reduced ROS 
production, we reasoned that macrophages 
expressing JMML-associated GOF Shp2 mutants 
(10,23), characterized to have increased 
phosphatase activity (10,36), would produce 
elevated zymosan- and SOZ-stimulated ROS 
levels.  To examine this hypothesis, we retrovirally 
introduced WT Shp2, Shp2-D61Y, or Shp2-E76K 
into murine bone marrow LDMNCs followed by in 
vitro differentiation to BMMs.  We demonstrated 
increased total Shp2 expression (compared to 
vector-transduced cells, Fig. 4A); however, the 
NADPH oxidase protein components were similar 
in all cells (Fig. 4A).  As anticipated, BMMs 
retrovirally expressing GOF Shp2-D61Y or GOF 
Shp2-E76K produced significantly elevated levels 
of ROS in response to zymosan and SOZ compared 
to BMMs retrovirally expressing WT Shp2 (Fig. 4B 
and 4C).  Additionally, Shp2-D61Y was strongly 
recruited to the SOZ-stimulated phagosomal cup 
and early phagosome, similar to that seen with WT 
Shp2 (Fig. 4D).  
 
To utilize a more physiologic model, we examined 
ROS production using PEMs from 
Shp2D61Y;Mx1Cre+ mice, in which Shp2D61Y is 
under the endogenous control of the Ptpn11 
promoter (21).  PEMs collected from the 
Shp2D61Y;Mx1Cre- and Shp2D61Y;Mx1Cre+ 
mice demonstrated a similar level of terminal 
differentiation based on F4/80 and Mac1 staining 
(Fig. 5A) and expressed similar levels of the 
NADPH oxidase components, p40phox, p22phox, and 
gp91phox (Fig. 5E).  Consistent with the retrovirally 
transduced cells, PEMs from Shp2D61Y;Mx1Cre+ 
mice produced substantially higher levels of 
zymosan- and SOZ-stimulated ROS compared to 
PEMs from Shp2D61Y;Mx1Cre- mice (Fig. 5B, 
5C, and 5D).  Using Shp2D61Y;Mx1Cre+  PEMs, 
we interrogated the Dectin-1-stimulated signaling 
pathway to further clarify the contribution of Syk, 
Shp2, Erk, and Akt activation to the elevated ROS 
production in response to zymosan.  As predicted, 
we found increased phospho-Shp2 and enhanced 
Erk activation in the GOF Shp2-expressing cells 
compared to control cells (Fig. 5E).  Akt activation 
was not substantially elevated in the Shp2D61Y-
expressing cells, suggesting Shp2 regulation of Erk 
activation is more relevant for zymosan-induced 
maximal ROS production.  Interestingly, Erk 
activation was sustained longer in these cells 
compared to that observed using WT PEMs (Fig. 1) 
or the bone marrow-derived macrophages from 
Shp2f/f;MxCre- mice (Fig. 2).  This difference in 
Erk inactivation kinetics might be due to a strain 
difference of the Shp2D61Y;Mx1Cre animals, 
which are on a mixed C57Bl/6-Sv129 background 
rather than a pure C57Bl/6 background.  
Notwithstanding, these findings are consistent with 
the need for Erk to be activated for maximal ROS 
production, however, suggest that Erk inactivation 
is not imperative for the return of ROS to baseline 
levels.  Consistent with previous results using R406 
(Fig. 1) and Shp2f/f;Mx1Cre+ BMMs (Fig. 2), Syk 
activation was not altered in the presence of GOF 
Shp2D61Y (Fig. 5E), again suggesting that Shp2 
functions downstream of Syk in the Dectin-1 
signaling pathway.  Together, these findings 
support a model placing Shp2 downstream of Syk 
in Dectin-1 signaling and indicate that Shp2 
phosphatase function positively regulates NADPH 
oxidase activity via promoting Erk activation. 
 
Erk activation promotes ROS production in 
response to zymosan stimulation.  Several 
previous studies have found that ROS per se 
functions as a signaling molecule to promote Erk 
activation (37).  These studies were performed in 
non-phagocytic cells, and typically the cells were 
cultured in supra-physiologic concentrations of 
H2O2.  On the other hand, other studies demonstrate 
that Erk promotes NADPH oxidase activation and 
ROS production (38-40).  To determine if Erk 
activation is upstream or downstream of ROS in 
zymosan-stimulated macrophages, we first 
examined zymosan-stimulated Erk activation in the 
presence of the conventional NADPH oxidase 
inhibitor, DPI.  Although incubation with DPI 
essentially obliterated zymosan-stimulated ROS, 
Erk activation was unchanged (Figs. 6A – 6C).  In 
concordance with these findings, bone marrow 
derived macrophages from X-CGD mice 
(gp91phox-/-) (41), which are devoid of ROS 
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production, also demonstrated no change in 
zymosan-stimulated phospho-Erk levels (data not 
shown).  We next treated cells with the Erk 
inhibitor, SCH772984, and found a significant 
reduction of ROS which correlated with reduced 
Erk activation (Figs. 6A, 6B, and 6C), suggesting 
that Erk functions upstream of zymosan-stimulated 
oxidative burst.  To further define the linear 
arrangement of Shp2, Erk, and ROS production, we 
examined the effect of Erk inhibition on ROS 
production in Shp2D61Y-expressing macrophages.  
Hyperactivated Erk in Shp2D61Y-expressing 
macrophages was reduced by treatment with 
SCH772984, similar to that observed with WT 
Shp2-expressing macrophages (Fig. 6D).  In a 
corresponding manner, inhibition with SCH772984 
reduced the enhanced ROS levels in the zymosan-
stimulated Shp2D61Y-expressing macrophages to 
near WT levels (Fig. 6E and 6F).  These findings 
support the hypothesis that Erk is downstream of 
Shp2 and upstream of NADPH oxidase and ROS 
production in zymosan-stimulated macrophages. 
 
Shp2 and phospho-SIRP co-localize on 
phagosomes and interact biochemically in 
Dectin-1-stimulated cells.  Given the positive role 
of Shp2 phosphatase function in promoting 
zymosan- and SOZ-stimulated ROS, we 
investigated putative Shp2 phosphatase substrates 
that might regulate Erk and NADPH oxidase 
activation.  SIRP (signal regulatory protein ) is a 
myeloid inhibitory immunoreceptor highly 
expressed on macrophages, requires tyrosine 
phosphorylation to exert its inhibitory effect, and 
has been shown to be a physiological substrate of 
Shp2 phosphatase (42,43).  Previous studies 
indicate that dephosphorylation of SIRP leads to 
increased NFB-stimulated expression of 
inflammatory cytokines and NADPH oxidase 
protein components such as gp91phox (19,44).  
However, as we see a rapid effect of the various 
Shp2 mutants on ROS production independent of 
the time needed for NFB-stimulated gene 
expression and protein synthesis, we anticipated 
that zymosan- or SOZ-stimulated SIRP 
dephosphorylation would be correlated with 
NADPH oxidase activation and ROS production. 
 
To address this hypothesis, we first examined the 
subcellular localization of SIRP in zymosan-
stimulated PEMs, and found that SIRP is strongly 
associated with the phagosome membrane at 10 
minutes post stimulation, which correlates 
kinetically with zymosan-stimulated Shp2 
activation and ROS production (data not shown).  
We next conducted co-localization studies between 
Shp2 and SIRP on the phagosome membrane at 
peak ROS production, and found that indeed Shp2 
and SIRP co-localize on phagosome membranes 
(Fig. 7A). However, the actual percentage of 
phagosomes showing co-localization of Shp2 and 
SIRP at peak ROS production was only 
approximately 10 – 15% of phagosomes.  Given the 
relatively low prevalence of Shp2-SIRP co-
localization at the time of peak ROS production, as 
well as the previous observation that phosphatase 
dead Shp2-C463A remained more strongly 
associated with the phagosome membrane 
compared to WT Shp2 (Fig. 3G), we hypothesized 
dephosphorylation of SIRP and disruption, rather 
than maintenance, of the Shp2-SIRP interaction is 
needed for maximal activation of NADPH oxidase. 
 
To examine this idea further, we examined 
zymosan-stimulated phospho-SIRP levels, and 
correlated phospho-SIRP with ROS production.  
As predicted, the phospho-SIRP level was lowest 
at the time of maximal ROS production (10’ post 
zymosan stimulation, Fig. 7B) and at the time of 
maximal Shp2 phosphorylation (Fig. 1B).  If SIRP 
is a substrate of Shp2 in response to phagocytic 
stimuli, we predicted that cells expressing 
phosphatase dead Shp2-C463A would 
demonstrated elevated phospho-SIRP levels in 
response to Dectin-1 stimulation.  Accordingly, we 
found substantially higher levels of phospho-
SIRP at baseline and in response to zymosan 
stimulation in the Shp2-C462A-expressing BMMs 
compared to the WT Shp2-expressing cells (Fig. 
7C).  Importantly, the elevated levels of phospho- 
SIRP  correlated to reduced levels of phospho-Erk 
(Fig. 7C), suggesting that Shp2 dephosphorylation 
of SIRP constrains the SIRP inhibitory function 
to permit normal Erk activation. 
 
These findings support a model whereby Shp2 
interacts with phosphorylated SIRP, and that upon 
SIRP dephosphorylation, Shp2 is released and 
available to augment activation of the Ras-Erk 
pathway, promote association of the NADPH 
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oxidase protein complex, and enhance production 
of ROS.  To address this hypothesis, we performed 
co-immunoprecipitation (co-IP) assays to examine 
the interaction between phospho-SIRP and WT 
Shp2 compared to Shp2-C463A.  While we did 
observe an interaction between WT Shp2 and 
phospho-SIRP (Fig. 7D), this interaction was in 
fact difficult to detect and required the use of 
approximately 3-fold more protein lysate for the co-
IP compared to the amount of lysate used to detect 
the very strong interaction between Shp2-C463A 
and phospho-SIRP (Fig. 7D).  The modest 
biochemical interaction observed between WT 
Shp2 and phospho-SIRP  is consistent with the 
relatively low number of phagosomes 
demonstrating WT Shp2 – SIRP co-localization 
upon zymosan stimulation (Fig. 7A), and supports 
the notion that Shp2 de-phosphorylation of SIRP 
and disruption of the Shp2-SIRP interaction is 
needed for optimal activation of Erk and NADPH 
oxidase. 
 
DISCUSSION 
Innate immune cell production of microbicidal 
ROS in response to foreign stimuli is vital for 
clearance of invading pathogens and 
immunocompetence.  However, ROS production 
needs to be regulated in a temporal and spatial 
manner to minimize non-specific damage to healthy 
tissues.  Within this manuscript, we have 
demonstrated that the protein tyrosine phosphatase, 
Shp2, is a novel player in the Dectin-1-stimulated 
signaling pathway and functions downstream of 
Syk and upstream of Erk to promote NADPH 
oxidase activation and oxidative burst. Further, we 
found that Shp2 activation and dephosphorylation 
of the inhibitory immunoreceptor, SIRP, 
correlates kinetically with peak ROS production in 
Dectin-1-stimulated macrophages. 
 
Shp2 is highly expressed in hematopoietic cells and 
has previously been shown to promote IL-6 
production by promoting activation of NFB (45).  
Additionally, Shp2 has been shown to be an 
important component of the Leptin Receptor 
signaling pathway in protecting against the parasite 
E. histolytica, and a component of this protection is 
due to STAT3-regulated IL-6 production (12).  
However, the role of Shp2 in oxidative burst has 
never been described.  We first found that cells 
bearing genetic disruption of Ptpn11 produce lower 
levels of zymosan- and SOZ-stimulated ROS.  
Using a series of Shp2 point mutants, we found that 
both the N-SH2 domain and the phosphatase 
domain of Shp2 are needed for zymosan- and SOZ-
stimulated ROS.  Importantly, videomicroscopy 
demonstrated that Shp2-R32K (N-SH2 domain 
mutant) failed to be recruited to the phagosome, 
while phosphatase dead Shp2-C463A was strongly 
recruited to phagosomes and was retained more 
intensely than WT Shp2 (Fig. 3G).  These findings 
indicate that the N-SH2 domain is needed for Shp2 
recruitment to the phagosome, however, once 
recruited, the phosphatase function of Shp2 is 
needed to promote ROS production.  Supporting 
this idea, GOF Shp2 mutants Shp2-D61Y and 
Shp2-E76K increased both zymosan- and SOZ-
stimulated ROS (Figs. 4 and 5).   
 
Given the apparent positive functional role of Shp2 
phosphatase on ROS production and the kinetic 
correlation of Erk activation with maximal ROS 
production (Fig. 1A and 1B), we reasoned that Shp2 
exerts its positive effect on NADPH oxidase 
activation via positive regulation of  Erk, as Shp2 
has been shown to positively upregulate Erk 
activation in response to multiple stimuli 
(34,46,47).  This notion is consistent with previous 
studies that have demonstrated positive regulation 
of Erk activation on NADPH oxidase (38-40).  We 
found that the Erk inhibitor, SCH772984, reduced 
ROS production in both WT cells and in cells 
expressing GOF Shp2D61Y (Fig. 6), placing Erk 
downstream of Shp2 and upstream ROS 
production. 
 
We next interrogated potential Shp2 substrates that 
may be involved in the regulation of particulate-
stimulated Erk activation and ROS production.  
SIRP, also known as SHPS-1/BIT/CD172a, was 
first identified as a phosphorylated glycoprotein 
that interacted with Shp2 in response to insulin 
stimulation, and expression of catalytically inactive 
Shp2 resulted in increased tyrosine phosphorylation 
of SIRP (48).  SIRP contains extracellular 
immunoglobulin-like domains and four 
intracellular tyrosine residues followed by amino 
acid sequence XX(L/V/I), indicating sites of 
tyrosine phosphorylation (43).  Several studies 
indicate that SIRP may be a physiological 
substrate for Shp2 (42,43).  Early functional studies 
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in fibroblasts indicated that over-expression of 
SIRP inhibited receptor tyrosine kinase- and 
cytokine receptor-stimulated cell proliferation, and 
that the intracellular tyrosine residues were vital for 
the SIRP inhibitory function (42).  Given the high 
expression level of SIRP in macrophages, 
investigators found that SIRP negatively 
modulates inflammatory cytokine production via 
downregulation of NFB-regulated expression 
(19,49).  Additionally, one study found that SIRP 
phosphorylation functioned to inhibit soluble 
stimulation (PMA)-induced plasma membrane 
ROS by down-regulating expression of the 
NADPH oxidase component, gp91phox (44). 
 
To date, however, no previous studies have 
identified SIRP as an important regulatory 
molecule in particulate-stimulated oxidative burst.  
We first defined that SIRP is indeed present on 
early phagosomal membranes in response to 
zymosan stimulation with similar kinetics to Shp2 
phagosomal recruitment.  In fluorescent 
microscopy studies, however, while we found that 
Shp2 and SIRP co-localize on the early 
phagosome (Fig. 7A), we were surprised to find that 
the co-localization was modest and seen in only 
approximately 10 – 15% of phagosomes at the time 
corresponding to maximal ROS production (10 
minutes post-stimulation).  These findings suggest 
that SIRP phosphorylation recruits Shp2 to the 
phagosome membrane, and that the Shp2-SIRP 
interaction delays the full oxidative burst by 
sequestering Shp2 from the Ras-Erk pathway and 
thus deferring maximal Erk activation and ROS 
production.  The increased association of 
phosphatase-dead Shp2-C463A with the 
phagosome (Fig. 3G) and the increased 
biochemical interaction between Shp2-C463A and 
SIRP (Fig. 7D) in conjunction with reduced ROS 
production support this model. 
 
While our data support a positive role for Shp2 
phosphatase in particulate-stimulated ROS 
production by dephosphorylating and thus 
repressing the inhibitory role of SIRP, it is 
important to put these findings into context with 
previous studies in this signaling pathway.  First, 
studies from the Eklund lab demonstrated that Shp2 
functions to de-phosphorylate the transcription 
factors ICSBP and HoxA10 resulting in reduced 
transcription and expression of the NADPH oxidase 
protein components gp91phox and p67phox (14,15).  
These studies very nicely provide a rational 
mechanism of how GOF Shp2 mutants may inhibit 
expression of genes needed for myeloid cell 
terminal differentiation, and thus promote 
leukemogenesis.   
 
Additionally, van Beek et al. demonstrated that 
ectopic expression of SIRP in PLB-985 cells 
functioned in an inhibitory manner by repressing 
gp91phox expression during granulocytic or 
monocytic differentiation, leading to reduced 
soluble stimulation (PMA)-induced ROS (44).  
Notably, these previous studies were performed in 
undifferentiated or differentiating myeloid cells, 
while our studies were performed in terminally 
differentiated macrophages.  Importantly, in 
terminally differentiated macrophages, we did not 
find a difference in expression of the various 
NADPH oxidase components in cells lacking Shp2 
(Fig. 2), expressing loss-of-function Shp2 mutants 
(Fig. 3), or gain-of-function Shp2 mutants (Figs. 4 
& 5).  Contrasting our studies to this previous work 
highlights an interesting concept that in 
undifferentiated myeloid cells, Shp2 and SIRP 
may be more important for regulating transcription 
factor function and myeloid cell differentiation 
(50,51), while in terminally differentiated cells, 
Shp2 and SIRP are more important for regulating 
phosphorylation and subcellular localization, 
respectively, of cytoplasmic signaling proteins. 
 
Further, while many studies focus on the inhibitory 
role of SIRP in myeloid cell immune function, 
others have found that SIRP can also play a 
positive role in immune cell function (52).  
Importantly, this positive regulatory role of 
SIRPwas found in the context of Shp1-expressing 
hematopoietic cells, while many of the original 
studies defining a negative regulatory role of 
SIRP were performed in fibroblasts which express 
only Shp2 (52).  As both Shp1 and Shp2 are 
expressed in hematopoietic cells and have both 
been found to interact with SIRP, and as Shp1 is 
conventionally thought to play a negative 
regulatory role and Shp2 is thought to play a 
positively regulatory role in hematopoietic cell 
function, these considerations bring into relief the 
speculative idea that Shp1 may function to 
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dephosphorylate and inhibit the positive regulatory 
role of SIRP (leading to a net negative signal), 
while Shp2 may function to dephosphorylate and 
inhibit the negative regulatory role of  
SIRPleading to a net positive signal).  Although 
beyond the point of the current study, it may be of 
interest to compare the effect of phosphatase dead 
Shp1 to that of phosphatase dead Shp2 in 
particulate-stimulated ROS production in 
terminally differentiated macrophages or 
neutrophils. 
 
Based on our findings within the current study, we 
have clarified a model that places Shp2 activation 
downstream of Dectin-1-stimulated Syk and 
upstream of Erk and ROS production (Fig. 8).  
Previous work defined that upon stimulation, 
Dectin-1 is phosphorylated (likely by members of 
the Src family of kinases) resulting in Syk 
recruitment, Ras-Erk pathway activation (16), and 
immediate production of ROS (Fig. 8A and 8B).  
Findings within this manuscript demonstrate that 
Dectin-1 stimulation leads to activation of Shp2 in 
a Syk-dependent manner, and that phospho-Shp2 is 
recruited to phosphorylated SIRP (Fig. 8B).  Once 
Shp2 dephosphorylates SIRP, Shp2 is available 
for additional positive regulation of the Ras-Erk 
pathway, leading to maximal ROS production (Fig. 
8C).  A potential means of Erk activation of 
NADPH oxidase function is phosphorylation of 
p47phox, which has been found previously in 
neutrophils (40,53).  It is possible that the SIRP 
interaction with Shp2 defers maximal ROS 
production for the purpose of mitigating or 
preventing unwarranted ROS release to normal 
tissues.  These findings also have application for 
improved understanding of the childhood leukemia, 
JMML, as aberrantly elevated ROS production 
from activating PTPN11-expressing innate immune 
cells may account for the common difficulty in 
clinically differentiating JMML from microbial and 
viral infections (54-56).  Collectively, our findings 
demonstrate that Shp2 positively regulates 
oxidative burst at least in part by promoting Erk 
activation, and that the Shp2-SIRP interaction 
may fine tune the optimal timing and location for 
ROS production. 
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Figure 1.  Zymosan-induced ROS production and the activation of Dectin-1-stimulated signaling 
molecules in WT mouse PEMs. (A) ROS production in 0.01×106 PEMs upon zymosan (400 g/ml) 
stimulation. (B) Immunoblot demonstrating phosphorylation of Syk, Shp2, Erk, and Akt at different time 
points during zymosan-triggered activation in mouse PEMs. (C) ROS production in 0.05×106 PEMs upon 
zymosan (400 g/ml) stimulation in the absence or presence of Syk inhibitor, R406 (5 m). (D) 
Immunoblot demonstrating phosphorylation of Syk, Shp2, Erk, and Akt at different time points during 
zymosan-triggered activation in mouse PEMs in the absence or presence of Syk inhibitor, R406 (5 m).  
10 g of cell lysate was used in immunoblotting. Assays were performed in triplicate. 
 
Figure 2.  Zymosan- or SOZ-induced ROS production and the activation of Dectin-1-stimulated 
signaling molecules in Shp2f/f;Mx1Cre- and Shp2f/f;Mx1Cre+ mouse BMMs. (A) Flow cytometry 
demonstrating the expression level of macrophage membrane markers Mac1 and F4/80 in 
Shp2f/f;Mx1Cre- and  Shp2f/f;Mx1Cre+ BMMs.  ROS production in 0.05×106 Shp2f/f;Mx1Cre- or 
Shp2f/f;Mx1Cre+ BMMs upon zymosan (B) or SOZ (C) stimulation. (D) ROS production compiled from 
3 independent experiments, n=3, *p<0.01 for Shp2f/f;Mx1Cre+ compared to Shp2f/f;Mx1Cre- in response 
to zymosan or SOZ.  (E)  Phagocytic index.  10,000 cells were analyzed by flow cytometry, and the 
phagocytic index for each cell type was calculated as described under “Experimental Procedures”.  (F) 
Representative immunoblot showing NADPH oxidase phox protein expression.  (G)  Representative 
immunoblot demonstrating phosphorylation of Shp2, Syk, Erk, and Akt at different time points during 
zymosan-triggered activation in Shp2f/f;Mx1Cre- and  Shp2f/f;Mx1Cre+ BMMs. 
 
Figure 3.  Expression of Shp2 mutants (Shp2-C463A and Shp2-R32K) leads to reduced zymosan- 
and SOZ-stimulated ROS production. (A) Localization of endogenous Shp2 upon SOZ stimulation, 
staining with anti-Shp2 (Santa Cruz, SC-280) and Alexa555-goat-anti-rabbit IgG in WT BMMS. Alexa 
Fluor® 488 phalloidin was used to stain F-actin, which specifies early phagosomes. Arrows and asterisks 
denote Shp2 accumulation on the phagosome cups and early phagosomes, respectively. Representative 
images from three independent experiments. (B) Structural motifs of YFP-tagged Shp2 constructs. (C) 
Flow cytometry indicating the expression level of YFP-tagged WT Shp2 (black), Shp2-C463A (red), or 
Shp2-R32K (blue). (D) Immunoblot demonstrating expression of YFP-tagged Shp2 and endogenous Shp2 
in transduced BMMs expressing YFP-tagged WT Shp2, Shp2-C463A, or Shp2-R32K as well as 
expression of NADPH oxidase components, gp91phox, p22phox, and p67phox. (E) Flow cytometry 
demonstrating the expression level of macrophage membrane markers Mac1 and F4/80 in the populations 
of BMMs expressing YFP-tagged WT Shp2, Shp2-C463A, or Shp2-R32K. (F) ROS production in BMMs 
expressing YFP-tagged WT Shp2, Shp2-C463A, or Shp2-R32K compiled from 3 independent 
experiments, n=3, *p<0.01 for Shp2-C463A v. WT or Shp2-R32K v. WT in response to SOZ or zymosan. 
(G) Distribution of YFP-tagged WT Shp2, Shp2-C463A, or Shp2-R32K during SOZ-induced 
phagocytosis in BMMs. Arrows indicate the cup of phagosomes, asterisks indicate the internalized 
phagosomes, bar=5m. 
 
Figure 4.  ROS generation in Shp2D61Y- and Shp2E76K-expressing BMMs.  (A) Immunoblot 
demonstrating Shp2 and phox protein expression in WT BMMs retrovirally expressing empty vector 
(MIEG3), WT Shp2, or GOF mutants, Shp2-D61Y and Shp2-E76K. (B-C) ROS production in 0.1×106 
BMMs expressing WT Shp2 or GOF mutants, Shp2-D61Y and Shp2-E76K upon zymosan or SOZ 
stimulation. (D) Localization of WT Shp2 and Shp2-D61Y upon SOZ stimulation, immunofluorescent 
staining with anti-Shp2 (Santa Cruz, SC-280) and Alexa555-goat-anti-rabbit IgG in WT BMMS. Alexa 
Fluor® 488 phalloidin (Life technologies) was used to stain F-actin. Arrows and asterisks denote Shp2 
accumulation on the phagosome cups and early phagosomes, respectively, bar=5m. 
 
Figure 5. ROS production and the activation of Dectin-1-stimulated signaling molecules in 
Shp2D61Y;Mx1Cre- and in Shp2D61Y;Mx1Cre+ mouse PEMs upon zymosan or SOZ stimulation. 
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(A) Flow cytometry demonstrating the expression level of macrophage membrane markers Mac1 and 
F4/80 in Shp2D61Y;Mx1Cre- and Shp2D61Y;Mx1Cre+ PEMs. (B-C) ROS production in 
Shp2D61Y;Mx1Cre- and Shp2D61Y;Mx1Cre+ PEMs upon zymosan and SOZ activation. (D) ROS 
production compiled from 3 independent experiments, n=3, *p<0.01 for Shp2D61Y;Mx1Cre+ v. 
Shp2D61Y;Mx1Cre- in response to zymosan or SOZ. (E) Representative immunoblot demonstrating 
protein level of phosphorylated and total Shp2, Syk, Erk, and Akt as well as phox proteins at various time 
points during zymosan-triggered activation in Shp2D61Y;Mx1Cre- and Shp2D61Y;Mx1Cre+ PEMs.   
 
Figure 6. Erk inhibition reduces zymosan-stimulated ROS production.  (A) Representative 
immunoblot demonstrating p-Erk levels during zymosan-triggered activation in the absence and presence 
of NADPH oxidase inhibitor, Diphenyleneiodonium chloride (DPI) or Erk inhibitor, SCH1772984 
(SCH). (B) ROS production in 0.1×106 WT PEMs in the presence of DPI or SCH. (C) ROS production 
compiled from 3 independent experiments, n=3, *p<0.0001comparing DPI-treated to vehicle-treated, and 
**p<0.01 for SCH-treated v. vehicle-treated. (D) Representative immunoblot demonstrating p-Erk levels 
in Shp2D61Y;Mx1Cre- and Shp2D61Y;Mx1Cre+ bone marrow-derived macrophages in the absence or 
presence of Erk inhibitor, SCH1772984 (SCH).  (E) ROS production in 0.03×106 Shp2D61Y;Mx1Cre- 
and Shp2D61Y;Mx1Cre+ bone marrow-derived macrophages in the absence or presence of SCH. (F) 
ROS production compiled from 3 independent experiments, n=3, *p<0.01 for SCH-treated v. vehicle-
treated in Shp2D61Y;Mx1Cre+ cells. 
 
Figure 7.  SIRP phosphorylation and interaction with Shp2 in zymosan-stimulated WT Shp2- and 
Shp2-C463A-expressing BMMs.  (A)  Co-localization of SIRP and Shp2 in WT mouse PEMs 10 
minutes post zymosan-induced phagocytosis, immunofluorescent staining with anti-SIRP (Abcam 
#53721) and anti-Shp2 (BD Bioscience, #610621), and Alexa568-goat-anti-rabbit IgG and goat488-anti-
mouse IgG1, respectively.  (B) Immunoblot demonstrating reduced levels of phospho-SIRP upon 
zymosan stimulation of WT PEMs.  (C) Phosphorylation of SIRP and Erk in BMMs retrovirally 
transduced with YFP-WT Shp2 or YFP-Shp2-C463A.  Total Shp2, SIRP, Erk, p22phox, and gp91phox 
were also examined using antibodies described in the “Experimental Procedures”.  (D)  Binding of WT 
Shp2 and Shp2-C463A mutant to tyrosine phosphorylated SIRP in macrophages before and post 
zymosan stimulation.  Cell lysates from macrophages expressing YFP-WT Shp2 or YFP-Shp2-C463A 
were subjected to immunoprecipitation (IP) anti-Shp2 antibody (SC-280, Santa Cruz Biotechnology) 
followed by immunoblotting (IB) with anti-phospho-SIRP or anti-Shp2 (#610621, BD Bioscience). 390 
g of protein lysis from macrophages expressing YFP-WT Shp2, and 130 g of protein lysis from 
macrophages expressing YFP- Shp2-C463A were used for IP. 10 g of protein lysis was used to do 
immunoblot analysis.  Data are representative of three separate experiments.   
 
Figure 8.  Schematic diagram indicating proposed mechanism of Shp2 and SIRP interaction in 
response to Dectin-1 stimulation.  (A) Cells at resting state.  (B)  Immediate Dectin-1-stimulated ROS 
production in a Syk-dependent, Shp2-independent manner.  (C)  Following Shp2 dephosphorylation of 
SIRPmaximal Dectin-1-stimulated ROS is produced in both a Syk-dependent and Shp2-dependent 
manner. 
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